Cubist Systematic Strategies LLC Boosts Position in Alignment Healthcare, Inc. $ALHC

Key Points

• Cubist Systematic Strategies LLC increased its stake in Alignment Healthcare, Inc. by 55.8%, now holding over 1 million shares valued at approximately $19.3 million.
• Alignment Healthcare reported a 49% year-over-year increase in quarterly revenue, amounting to $1.02 billion, and earnings per share surpassed analysts' expectations.
• Various analysts have upgraded their ratings for Alignment Healthcare, with a consensus target price of $18.83, suggesting a moderate buy outlook.

Cubist Systematic Strategies LLC increased its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 55.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,038,203 shares of the company's stock after purchasing an additional 371,980 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.52% of Alignment Healthcare worth $19,331,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MCF Advisors LLC lifted its stake in Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after buying an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new stake in Alignment Healthcare in the first quarter valued at approximately $42,000. Amalgamated Bank lifted its stake in Alignment Healthcare by 21.6% in the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after buying an additional 616 shares during the last quarter. Regal Partners Ltd purchased a new stake in Alignment Healthcare in the first quarter valued at approximately $194,000. Finally, CWM LLC lifted its stake in Alignment Healthcare by 137.6% in the first quarter. CWM LLC now owns 10,553 shares of the company's stock valued at $196,000 after buying an additional 6,112 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Alignment Healthcare Price Performance

Alignment Healthcare stock opened at $16.36 on Friday. Alignment Healthcare, Inc. has a 12 month low of $8.65 and a 12 month high of $21.06. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66. The business has a 50 day simple moving average of $13.93 and a 200-day simple moving average of $15.34. The stock has a market capitalization of $3.24 billion, a PE ratio of -58.43 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. During the same quarter in the prior year, the company posted ($0.13) earnings per share. Alignment Healthcare's quarterly revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Activity

In other Alignment Healthcare news, insider Hyong Kim sold 24,800 shares of the company's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $16.00, for a total value of $396,800.00. Following the sale, the insider owned 447,367 shares of the company's stock, valued at approximately $7,157,872. This represents a 5.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction on Monday, July 14th. The shares were sold at an average price of $13.44, for a total value of $403,200.00. Following the completion of the sale, the president directly owned 2,042,899 shares in the company, valued at $27,456,562.56. This trade represents a 1.45% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 636,185 shares of company stock valued at $9,235,468 over the last three months. 7.00% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price objective for the company in a research note on Monday, August 25th. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Wall Street Zen cut Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat, Alignment Healthcare has an average rating of "Moderate Buy" and a consensus target price of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.